Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit.

Annals of hepatology - 1 Jan 2000

Vafiadis Irene, Trilianos Panagiotis, Vlachogiannakos Jiannis, Karagiorga Markisia, Hatziliami Antonia, Voskaridou Ersi, Ladas Spiros D

Abstract excerpt

BACKGROUND: HCV infection and transfusional iron overload in Thalassemic patients may result in liver disease. HCV treatment in Thalassemia has raised safety concerns. AIM: Estimate effectiveness and tolerability of interferon-based therapy in HCV-infected Thalassemic patients. MATERIAL AND METHODS: Over a 12-year period, consecutive patients with β Thalassemia major (TM) and chronic hepatitis C received...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta-Thalassemia
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Liver Cirrhosis

Share to Polyethylene Glycols

Share to Proportional Hazards Models

Source

Identifiers

PMID: 23813130

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years audit.PMID 23813130Read ↗

Efficacy of Interferon A-2b monotherapy in Β-thalassemics with chronic hepatitis C.Semantic proximity Read ↗

Sofosbuvir/Ledipasvir for Treatment of Chronic Hepatitis C Infection in Adult Patients with β- Thalassemia Major: A Real-Life Study.Semantic proximity Read ↗

Response to interferon alfa-2b therapy in mutitransfused children with beta-thalassemia and chronic hepatitis C.Semantic proximity Read ↗

Effectiveness And Safety Of Direct Acting Antiviral Agents In Thalassaemic Patients With Chronic Hepatitis C.Semantic proximity Read ↗

Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis.Semantic proximity Read ↗

Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?Semantic proximity Read ↗

Study of Hepatitis C Virus infection among multi-transfused patients with inherited β-globin synthesis gene defect, in the eastern region of IndiaSemantic proximity Read ↗

Post-transfusion hepatitis C virus infection among β-thalassaemic individuals with associated clinical parameters.Semantic proximity Read ↗

A multicenter prospective study on the risk of acquiring liver disease in anti-hepatitis C virus negative patients affected from homozygous beta-thalassemia.Semantic proximity Read ↗

Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia.Semantic proximity Read ↗

Efficacy and Safety of Direct Acting Antiviral Therapy for Chronic Hepatitis C in Thalassemic Children.Semantic proximity Read ↗

Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.